Cantel

Censis Technologies and Cantel Medical Enter Into Partnership to Develop Differentiated Endoscope Reprocessing Software Solution

Retrieved on: 
Monday, December 7, 2020

Today, Censis Technologies, a wholly owned subsidiary of Fortive Corporation, and Cantel Medical Corp announced a new long-term partnership to combine Cantels leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.

Key Points: 
  • Today, Censis Technologies, a wholly owned subsidiary of Fortive Corporation, and Cantel Medical Corp announced a new long-term partnership to combine Cantels leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.
  • The new enhanced, co-branded software solution will combine the CANEXIS Integrated Workflow Solution for Endoscopy from Cantel with Censis CensiTrac surgical asset management software to create the leading instrument reprocessing and scope tracking software available to the market.
  • We are thrilled to be partnering with Censis on this critical endeavor, said Michael Spicer, President, Medical Business Unit at Cantel.
  • Censis Technologies, based in Franklin, Tennessee, is the leader in surgical instrument and asset management software.

Cantel Announces Senior Leadership Promotions in Dental

Retrieved on: 
Thursday, December 3, 2020

LITTLE FALLS, N.J., Dec. 3, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) announced today the appointment of Andy Xilas to President, Cantel Dental effective January 1, 2021.

Key Points: 
  • LITTLE FALLS, N.J., Dec. 3, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) announced today the appointment of Andy Xilas to President, Cantel Dental effective January 1, 2021.
  • In addition, Jennifer Naylor has been appointed to the newly created role of Senior Vice President, Infection Prevention and Control Strategy and Education for Cantel.
  • Mr. Xilas and Ms. Naylor both joined Cantel in 2019, as part of Cantel's acquisition of Hu-Friedy and will sit on the Company's Executive Leadership Team.
  • He leaves in place a great leadership team capable of continuing the growth of Cantel Dental.

Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2020

Retrieved on: 
Tuesday, November 24, 2020

LITTLE FALLS, N.J., Nov. 24, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its first quarter ended October 31, 2020 on Tuesday, December 8, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.

Key Points: 
  • LITTLE FALLS, N.J., Nov. 24, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its first quarter ended October 31, 2020 on Tuesday, December 8, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.
  • To participate in the conference call, dial 1-844-602-0380 (US & Canada) or 1-862-298-0970 (International) approximately 5 to 10 minutes before the beginning of the call.
  • A replay of the presentation will be archived on the Cantel website for those unable to listen live.
  • In addition, the Company will provide a supplemental presentation to complement the conference call.

Cantel Hires Michael Drexel to SVP and Chief Technology Officer

Retrieved on: 
Thursday, October 1, 2020

LITTLE FALLS, N.J., Oct. 1, 2020 /PRNewswire/ --CANTEL MEDICAL CORP (NYSE:CMD) announced today that Michael Drexel has been hired as Senior Vice President and Chief Technology Officer reporting to George Fotiades, Chief Executive Officer.

Key Points: 
  • LITTLE FALLS, N.J., Oct. 1, 2020 /PRNewswire/ --CANTEL MEDICAL CORP (NYSE:CMD) announced today that Michael Drexel has been hired as Senior Vice President and Chief Technology Officer reporting to George Fotiades, Chief Executive Officer.
  • Mr. Drexel has extensive leadership in product development including driving continuous improvement and developing management, engineering and technical talent.
  • George Fotiades, Chief Executive Officershared, "We are excited to welcome Michael to Cantel, he has a proven track record of successfully leading technology teams in the drive for continuous improvement in product development through to product launch."
  • With more than 25 years of experience across various manufacturing sectors, including medical device, Mr. Drexel brings strong leadership and technical acumen to the role.

Avanos Medical, Inc. Appoints Michelle Scharfenberg as Senior Vice President & Chief Ethics and Compliance Officer

Retrieved on: 
Tuesday, September 15, 2020

ALPHARETTA, Ga., Sept. 15, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michelle Scharfenberg has been named as the company's senior vice president & chief ethics and compliance officer.

Key Points: 
  • ALPHARETTA, Ga., Sept. 15, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michelle Scharfenberg has been named as the company's senior vice president & chief ethics and compliance officer.
  • In this role, Scharfenberg will be responsible for leading the Avanos Compliance & Ethics (C&E) program, which operationalizes Avanos's commitment to ethical and legally compliant operations.
  • Previously, Scharfenberg served as vice president and chief compliance officer for Cantel Medical Corporation, a leading provider of infection prevention products and services in the healthcare market.
  • "I am very pleased to have Michelle join Avanos in this role," stated Joe Woody, chief executive officer.

Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Fourth Quarter Ended July 31, 2020

Retrieved on: 
Thursday, September 3, 2020

LITTLE FALLS, N.J., Sept. 3, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its fourth quarter ended July 31, 2020 on Thursday, September 17, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.

Key Points: 
  • LITTLE FALLS, N.J., Sept. 3, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its fourth quarter ended July 31, 2020 on Thursday, September 17, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.
  • To participate in the conference call, dial 1-844-369-8770 (US & Canada) or 1-862-298-0840 (International) approximately 5 to 10 minutes before the beginning of the call.
  • A replay of the presentation will be archived on the Cantel website for those unable to listen live.
  • In addition, the Company will provide a supplemental presentation to complement the conference call.

Avanos Medical, Inc. Appoints Bill Haydon as Senior Vice President & General Manager, Pain Franchise

Retrieved on: 
Monday, August 31, 2020

ALPHARETTA, Ga., Aug. 31, 2020 /PRNewswire/ --Avanos Medical, Inc. (NYSE: AVNS) today announced that Bill Haydon has been appointed senior vice president & general manager for the company's newly combined pain franchise.

Key Points: 
  • ALPHARETTA, Ga., Aug. 31, 2020 /PRNewswire/ --Avanos Medical, Inc. (NYSE: AVNS) today announced that Bill Haydon has been appointed senior vice president & general manager for the company's newly combined pain franchise.
  • In this role, Haydon will spearhead a global strategy to support transformation and growth in this business.
  • Previously, Haydon served as senior vice president and general manager for the medical division of Cantel, a leading provider of infection prevention products and services in the healthcare market.
  • Haydon brings to Avanos nearly 25 years of experience in strategy, marketing, commercialization, innovation, M&A strategy development and execution.

Global Sterilization Services Market 2020-2025 - Major Players arae Johnson & Johnson, Steris Corporation, Stryker Corporation, Medistri, and Cantel Medical

Retrieved on: 
Thursday, June 25, 2020

With the high usage of complex equipment across medical and food processing facilities, the sterilization services are an important practice for a healthy ecosystem.

Key Points: 
  • With the high usage of complex equipment across medical and food processing facilities, the sterilization services are an important practice for a healthy ecosystem.
  • In healthcare facilities, hospital-acquired infections also play a crucial role to include the sterilization methods on a regular basis.
  • The major market players are focusing on technological advancements and investing more upon the services to the established facilities across industries.
  • Some of the major players in the market are Johnson & Johnson, Steris Corporation, Stryker Corporation, Medistri, and Cantel Medical, among others.

Surface Disinfectants: World Market Assessment 2020-2025 - ResearchAndMarkets.com

Retrieved on: 
Monday, June 22, 2020

The Global Surface Disinfectant Market is expected to witness a CAGR of 9.95% during the forecast period.

Key Points: 
  • The Global Surface Disinfectant Market is expected to witness a CAGR of 9.95% during the forecast period.
  • Owing to all these factors the region is expected to hold the largest market share in the global market during the forecast period.
  • The global Surface Disinfectant market is highly competitive and consists of a number of major players.
  • Companies like 3M Company, Cantel Medical Corporation, Ecolab, Procter and Gamble, SC Johnson Professional, Steris Corporation, The Clorox Company, Whiteley Corporation, among others, hold the substantial market share in the Surface Disinfectant market.

Cantel Medical Reports Financial Results for its Third Quarter Fiscal Year 2020

Retrieved on: 
Thursday, June 4, 2020

LITTLE FALLS,N.J., June 4, 2020 /PRNewswire/ --Cantel Medical Corp. (NYSE: CMD) today announced financial results for its third quarter ended April30, 2020.

Key Points: 
  • LITTLE FALLS,N.J., June 4, 2020 /PRNewswire/ --Cantel Medical Corp. (NYSE: CMD) today announced financial results for its third quarter ended April30, 2020.
  • In the weeks following the end of its third quarter, the Company has made significant progress in solidifying its financial position.
  • The Company will hold a conference call to discuss the results for its third quarter ended April30, 2020 on Thursday, June4, 2020 at 8:30 a.m.Eastern Time.
  • Our estimated unaudited financial results presented above are preliminary and are subject to the close of the quarter, completion of our quarter-end closing procedures and further financial review.